8-K: T3 Defense Sells AI Subsidiary Zorronet to BiomX
Completion of Acquisition or Disposition of Assets
T3 Defense Inc. announced the completion of its subsidiary Water IO Ltd.'s sale of Zorronet to BiomX Inc. for BiomX common stock and a promissory note.
Summary
- T3 Defense Inc. reported the sale of its subsidiary, Zorronet, by its majority-owned Israeli company Water IO Ltd. to BiomX Inc. on April 10, 2026.
- Zorronet is an AI defense technology company specializing in computer vision and autonomous surveillance systems.
- The sale was conducted through a Stock Purchase Agreement (SPA) where BiomX issued 1,300,000 shares of its common stock and a $1,250,000 promissory note to Water IO.
- BiomX also assumed certain obligations related to Zorronet's founders and former shareholders, including a performance-based earnout and key personnel retention.
- As a result of the transaction, Water IO holds approximately 16.57% of BiomX's outstanding common stock, which T3 Defense may be deemed to beneficially own indirectly.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive development, as it represents a successful divestiture of a subsidiary and provides T3 Defense with an equity stake in another public company, though the ultimate value is contingent on future performance.
Positives
- Completion of the sale of Zorronet, an AI defense technology subsidiary, to BiomX Inc.
- Receipt of 1,300,000 shares of BiomX common stock as part of the consideration.
- Acquisition of a $1,250,000 non-convertible promissory note from BiomX.
- BiomX's assumption of certain obligations, including a performance-based earnout and key employee retention, mitigating potential liabilities for Water IO.
- Water IO now holds a significant stake (approx. 16.57%) in BiomX, offering potential future upside.
Negatives
- The promissory note is non-convertible, limiting potential equity upside from that component.
- The earnout payment is contingent on Zorronet's 2026 fiscal year performance (revenue or EBITDA), introducing uncertainty.
- BiomX's stock performance will directly impact the value of the share consideration received by Water IO.
- The agreement includes a clause allowing Water IO to terminate the agreement and reclaim Zorronet shares if the note is not paid or BiomX stock is delisted for 90 days.
Risks
- The value of the consideration received is subject to the market performance of BiomX's common stock.
- The earnout payment is dependent on Zorronet's future financial performance in fiscal year 2026.
- There is a risk that BiomX may not fulfill its obligations regarding the promissory note or key employee retention.
- Water IO has the option to terminate the agreement and reclaim Zorronet if BiomX's stock is not listed on the NYSE for 90 days after the registration statement is effective or shares can be sold under Rule 144.
Future Outlook
The future outlook for T3 Defense is indirectly tied to the performance of Water IO's stake in BiomX and the potential earnout payment from the Zorronet sale. BiomX is expected to file a registration statement for the resale of the acquired shares within 45 days of closing.
Management Comments
- Menachem Shalom, CEO of T3 Defense Inc., signed the Form 8-K, indicating his authorization of the report.
- Michael Oster, CEO of BiomX Inc., signed the Stock Purchase Agreement and the Promissory Note.
Industry Context
StockSavvy.ai notes that this transaction reflects a trend of consolidation and strategic divestitures within the defense technology sector, particularly involving AI and autonomous systems. Companies are seeking to monetize specialized assets or focus on core competencies, while buyers are acquiring innovative technologies to enhance their offerings.
Comparison to Industry Standards
- The earnout structure (125% of revenue or 8x EBITDA) is a common mechanism in technology acquisitions, though the multiples can vary significantly based on growth rates, market position, and technology maturity. For AI defense tech, an 8x EBITDA multiple is within a reasonable range, but the 125% revenue component suggests a focus on top-line growth.
- The assumption of key employee retention for three years is standard practice to ensure continuity of operations and knowledge transfer post-acquisition.
- The $1.25 million promissory note is a relatively modest amount for an acquisition of this nature, suggesting that the primary value is derived from the equity stake and the earnout potential.
Stakeholder Impact
- Shareholders of T3 Defense: May benefit from the indirect ownership of BiomX shares and potential future value realization, but the immediate impact is diluted by the fact that Water IO is a majority-owned subsidiary.
- Shareholders of BiomX: Will experience dilution from the issuance of 1,300,000 new shares. The value of their investment will depend on the integration and performance of Zorronet's technology.
- Founders and Former Shareholders of Zorronet: Are beneficiaries of the earnout payment and have rights to enforce key employee retention terms.
- Key Employees of Zorronet: Are assured of employment terms no less favorable for at least three years, subject to certain conditions.
Next Steps
- BiomX Inc. is required to file a registration statement on Form S-3 (or other applicable form) with the SEC within 45 days following the Closing Date.
- BiomX must maintain the effectiveness of the registration statement until all covered shares are sold or can be sold without restriction under Rule 144.
- The earnout payment is due no later than March 31, 2027, based on Zorronet's fiscal year 2026 performance.
- BiomX must retain key Zorronet personnel for at least three years from the Closing Date.
Key Dates
| Date | Description |
|---|---|
| 2026-03-31 | Latest date for Earnout Payment to Founder Beneficiaries. |
| 2026-04-10 | Effective Date and Closing Date of the Stock Purchase Agreement. |
| 2026-04-10 | Date of Report (Earliest event reported). |
Recommendation
holdThe filing details a strategic divestiture where T3 Defense's subsidiary receives BiomX stock and a note. While this diversifies assets, the ultimate value is contingent on BiomX's performance and Zorronet's future earnout. Without more direct financial performance data from T3 Defense itself, a 'hold' recommendation is prudent, awaiting further clarity on the value realization from the BiomX stake.
Keywords
T3 Defense, BiomX, Zorronet, Water IO, Acquisition, AI Defense Technology, Computer Vision, Stock Purchase Agreement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.